Dyno Therapeutics
Watertown, US · Founded 2018 · 95 employees on LinkedIn · 9 known investors
Find your way into Dyno Therapeutics
2,115 people in our graph share verified history with the Dyno Therapeutics team — schools, employers, funds. One of them is your warm intro.
Yaryna Nychunlockedknows Sam Sinai · together at Harvard University (overlapped)
knows the team · via Flagship Ventures
×3knows the team · via Broad Institute of MIT and Harvard
×2knows the team · via Harvard Medical School
×3knows the team · via Harvard University
×2knows the team · via Massachusetts Institute of Technology
Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases. The company works with pharmaceutical partners including Novartis, Sarepta, Roche, Spark, and Astellas to advance therapies for patients with genetic disorders.
Founders & leadership
EK
Eric Kelsicin𝕏CEO & CofounderEric Kelsic is CEO and co-founder of Dyno Therapeutics, which uses machine learning to engineer adeno-associated virus capsids for gene therapy applications in treating genetic diseases.
SS
Sam Sinaiin𝕏Vice President, Head of ML & CofounderHe joined Dyno Therapeutics as a machine learning research lead and moved through director and senior director roles before taking on the VP position. Prior to that, he was a researcher at the Wyss Institute for Biologically Inspired Engineering and worked on computer vision research and teaching in artificial intelligence at MIT and CSAIL.
AV
Adrian Veresin𝕏Chief Scientific Officer & CofounderHe co-founded the company in 2018 and became its Chief Scientific Officer in 2023, having previously been a postdoctoral research fellow at Harvard University.
GC
George ChurchinScientific Cofounder, SABGeorge Church is a professor at Harvard and MIT who has led foundational work in DNA sequencing and genomics, including methods for genome sequencing and molecular barcoding described in a 1984 PhD from Harvard. He has founded or co-founded multiple biotechnology companies spanning genomics, gene editing, and synthetic biology, and directs PersonalGenomes.org, which provides open-access genomic and trait data.
TB
Tomas BjorklundinScientific Co-founder, SABTomas Bjorklund is a scientific co-founder of Dyno Therapeutics, where he works on AI-driven engineering of viral vectors for gene therapy applications. He has founded four biotech companies and holds a PhD, with research focused on using machine learning and molecular biology techniques combined with human cell models to develop therapeutics for neurological disorders.
AC
Alan CraneExecutive Chairman & Cofounder, Polaris Entrepreneur PartnerEntrepreneur Partner at Polaris Partners
Investors · 9
Andreessen HorowitzMenlo Park · $500K – $50M
CRV (Charles River Ventures)Bay Area · $250K – $5M
GENERAL INCEPTIONPalo Alto
GV (Google Ventures)Mountain View · $250K – $50M
Lux CapitalNew York · $100K – $100M
Obvious VenturesSan Francisco · $250K – $6M
Casdin CapitalreportedNew York
KdT Venturesreported · 2 sourcesAustin · $500K – $3M
Polaris PartnersreportedBoston · $500K – $5M
Funding
SEC filings, press & company announcements- Undisclosed amountSeedMay 2020Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
3 people who came through Dyno Therapeutics went on to found or lead other companies.
Competitors · 2
by search overlap
AskBio15 shared keywordsAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.
Danaher11 shared keywordsDanaher is a global science and technology company specializing in biotech, diagnostics, and life sciences with businesses that innovate in drug development, molecular diagnostics, genomic medicine, and bioprocessing to help advance human health. Operating through multiple strategic platforms and with nearly 63,000 employees, Danaher develops technologies and solutions for researchers, biopharmaceutical producers, and healthcare systems globally.
Companies competing with Dyno Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Dyno Therapeutics do?
- Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases. The company works with pharmaceutical partners including Novartis, Sarepta, Roche, Spark, and Astellas to advance therapies for patients with genetic disorders.
- Who founded Dyno Therapeutics?
- Dyno Therapeutics was founded by Eric Kelsic, Sam Sinai, Adrian Veres, George Church, Tomas Bjorklund, Alan Crane in 2018.
- Who are Dyno Therapeutics's investors?
- Dyno Therapeutics's investors include Andreessen Horowitz, CRV (Charles River Ventures), GENERAL INCEPTION, GV (Google Ventures), Lux Capital, Obvious Ventures, Casdin Capital, KdT Ventures and 1 more.
- Where is Dyno Therapeutics headquartered?
- Dyno Therapeutics is headquartered in Watertown, US.